Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Nine companies including Hitachi complete automated testing of DCJPY inter-company transactions

Nine companies including Hitachi complete automated testing of DCJPY inter-company transactions

金色财经金色财经2026/05/30 02:15
Show original
Jinse Finance reported that on May 30, the Japanese conglomerate Hitachi, Ltd. announced the completion of an inter-company transaction test based on the yen tokenized deposit DCJPY, together with 9 other companies including Decurret DCP, Fujitsu, Kao Group Customer Marketing, and Tsuruha Holdings. Through the Invoice Chain platform, co-developed by Hitachi, the test connected inter-company order and delivery data with the DCJPY settlement process, automatically generating reconciliation documents for accounts receivable write-off and achieving automation from order processing and payment settlement to write-off and accounting operations. (NADA NEWS)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.

The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.

智通财经2026/09/21 07:31

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11